Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
British Journal of Pharmacology|April 6, 2021
Behavioural and pharmacological effects of cannabidiol (CBD) and the cannabidiol analogue KLS-13019 in mouse models of pain and reinforcementJeffery D Foss, Daniel J Farkas, Lana M Huynh, et al.
Diabetes, Obesity & Metabolism|September 23, 2024
A novel, centrally acting mammalian aminosterol, ENT-03, induces weight loss in obese and lean rodentsDenise Barbut, William A Kinney, Hsiao-Huei Chen, et al.
ACS Medicinal Chemistry Letters|April 21, 2016
Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, with Improved Potency, Safety, and PermeabilityWilliam A Kinney, Mark E McDonnell, Hua Marlon Zhong, et al.
Journal of Forensic Sciences|July 2, 2019
4F-MDMB-BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic CaseworkAlex J Krotulski, Amanda L A Mohr, Sherri L Kacinko, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2008
Thrombogenic collagen-mimetic peptides: Self-assembly of triple helix-based fibrils driven by hydrophobic interactionsMabel A Cejas, William A Kinney, Cailin Chen, et al.
Bioorganic & Medicinal Chemistry|February 24, 2006
Selection of a 2-azabicyclo[2.2.2]octane-based alpha4beta1 integrin antagonist as an inhaled anti-asthmatic agentEdward C Lawson, Rosemary J Santulli, Alexey B Dyatkin, et al.
Journal of Medicinal Chemistry|September 8, 2009
Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunitsEdward C Lawson, Diane K Luci, Shyamali Ghosh, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: synthesis, SAR, and in vivo assessmentDiane K Luci, Shyamali Ghosh, Charles E Smith, et al.
Journal of Medicinal Chemistry|July 11, 2023
Quantitative Attribution of the Protective Effects of Aminosterols against Protein Aggregates to Their Chemical Structures and Ability to Modulate Biological MembranesSilvia Errico, Giacomo Lucchesi, Davide Odino, et al.
The Journal of Organic Chemistry|February 19, 2008
Suzuki-Miyaura approach to JNJ-26076713, an orally active tetrahydroquinoline-containing alphaVbeta3/alphaVbeta5 integrin antagonist. enantioselective synthesis and stereochemical studiesWilliam A Kinney, Christopher A Teleha, Andrew S Thompson, et al.
Pageof 3